The Claim
In adults with chronic kidney disease and metabolic acidosis, sodium citrate reduces the incidence of gastrointestinal side effects to 10% over 12 months, compared to a 25% incidence with sodium bicarbonate.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults with chronic kidney disease and metabolic acidosis, sodium citrate results in 10% gastrointestinal side effects over 12 months, while sodium bicarbonate results in 25% gastrointestinal side effects over the same period.
See the scientific wording
Among adults with chronic kidney disease and metabolic acidosis, sodium citrate reduces gastrointestinal side effects to 10% over 12 months, compared to 25% with sodium bicarbonate, indicating superior tolerability that may improve long-term treatment adherence.
Sodium citrate is absorbed without reacting in the stomach, then converted to bicarbonate in the liver, which slowly releases into the blood. This avoids sudden gas production in the stomach that happens when sodium bicarbonate breaks down right away, so the stomach does not swell or cause nausea.
What the research says
1 studyThe study found that people with kidney disease who took sodium citrate had fewer stomach problems like bloating and nausea (10%) than those who took sodium bicarbonate (25%), making it easier to keep taking the medicine long-term.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.